PE000655
Jump to navigation
Jump to search
| Name | R.SWPAVGN[H5N4FS2]CSSALR.W |
|---|---|
| Sequence | SWPAVGNCSSALR |
| Glycans(s) | H5N4FS2 (N7) |
| Mod(s) | 57.021 (C8) |
| Molecular Weight | 3772.502 |
| Norm. RT | 51.132 |
| Protein | HPX (P02790) |
Samples
DDA Transition Groups
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Inst. | Sample | Transitions | |
|---|---|---|---|---|---|---|---|---|
| TG001397 | 33.154 | 32.785 | 51.688 | 1,252.509 | 3 | Orbitrap | Human Serum | 6 |
| TG002365 | 33.512 | 32.938 | 51.132 | 1,252.509 | 3 | Orbitrap | Human Serum | 8 |
| TG005273 | 54.819 | 54.797 | 61.965 | 1,252.509 | 3 | Orbitrap | Human Serum | 7 |
| TG003754 | 34.386 | 34.634 | 49.932 | 1,252.509 | 3 | Orbitrap | Human Serum | 8 |
| TG005479 | 55.017 | 55.096 | 63.106 | 1,252.509 | 3 | Orbitrap | Human Serum | 6 |
DIA Transition Groups
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Inst. | Sample | Intensity | |
|---|---|---|---|---|---|---|---|---|
| TG006431 | 33.381 | 33.381 | 52.748 | 1,252.509 | 3 | Orbitrap | Human Serum | 14,843,600 |
| TG008300 | 28.677 | 28.677 | 48.598 | 1,252.509 | 3 | TripleTOF | Human Serum | 331,216 |
| TG008611 | 28.765 | 28.765 | 44.782 | 1,252.509 | 3 | TripleTOF | Human Serum | 330,339 |
| TG008902 | 28.719 | 28.719 | 43.058 | 1,252.509 | 3 | TripleTOF | Human Serum | 317,456 |
| TG009518 | 28.731 | 28.731 | 46.830 | 1,252.509 | 3 | TripleTOF | Human Serum | 238,250 |
| TG009226 | 28.248 | 28.248 | 47.339 | 1,252.509 | 3 | TripleTOF | Human Serum | 224,889 |
| TG010391 | 28.702 | 28.702 | 47.783 | 1,252.509 | 3 | TripleTOF | Human Serum | 112,692 |
| TG006496 | 27.464 | 27.464 | 50.547 | 1,252.509 | 3 | TripleTOF | Human Serum | 586.271 |